# Vasa Therapeutics jobs and careers

> 0 open roles at Vasa Therapeutics as of October 24, 2026. Source: https://www.thejobsmap.com/company/vasa-therapeutics

Vasa Therapeutics is a San Diego-based, private biotechnology company committed to the discovery and development of therapeutics that target pathophysiology of cardiovascular aging. Vasa Therapeutics has three active preclinical programs: 1. VS-041 is the first personalized medicine-based treatment of HFpEF. VS-041 shows robust reduction of cardiac fibrosis in a preclinical HFpEF model and inhibits release of signaling collagen fragments, such as PRO-C6, that mediate fibroinflammatory responses and are biomarkers of worse outcomes in HFpEF patients. Phase 1 clinical trial of VS-041 is planned for 2024. 2. Long acting apelin peptide analogs for combination treatment with incretins in obesity patients at risk for skeletal muscle loss or cardiovascular disease. As a monotherapy, long acting apelin agonists could also be beneficial in muscle atrophy, heart failure, chronic kidney disease, and peripheral artery disease. 3. A best-in-class inhibitor of CamKIId for heart failure and life-threatening arrhythmias.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Employees | 11 to 50 |
| Total funding | $8.3M |
| Industries | Biopharma |
| Website | https://vasatherapeutics.com |

## Leadership

- Artur Plonowski, CEO and Co-Founder

## Common questions

### Is Vasa Therapeutics hiring right now?

Vasa Therapeutics has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Vasa Therapeutics's careers site.

### Who leads Vasa Therapeutics?

Artur Plonowski, CEO and Co-Founder, is at the top of Vasa Therapeutics's org chart.

### How do I apply for a job at Vasa Therapeutics?

Pick a role on Vasa Therapeutics's TheJobsMap page and select Apply. Every listing links to the original posting on Vasa Therapeutics's own careers site, so you apply directly with the employer.